HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Subash Babu Selected Research

Advanced Glycation End Products

11/2021Diminished Circulating Levels of Angiogenic Factors and Rage Ligands in Helminth-Diabetes Comorbidity and Reversal Following Anthelmintic Treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Subash Babu Research Topics

Disease

74Infections
04/2024 - 03/2005
61Tuberculosis (Tuberculoses)
01/2024 - 07/2009
41Pulmonary Tuberculosis
02/2023 - 12/2012
29Latent Tuberculosis
02/2023 - 07/2009
26Inflammation (Inflammations)
10/2023 - 04/2011
20COVID-19
02/2024 - 01/2021
20Lymph Node Tuberculosis (Scrofula)
02/2023 - 01/2013
14Coinfection
01/2022 - 07/2009
14Filarial Elephantiasis (Lymphatic Filariasis)
01/2022 - 06/2005
12Type 2 Diabetes Mellitus (MODY)
04/2024 - 04/2012
9Diabetes Mellitus
04/2024 - 10/2013
6Lymphedema (Milroy Disease)
12/2014 - 03/2005
5Insulin Resistance
12/2023 - 11/2013
4Malnutrition (Nutritional Deficiencies)
01/2022 - 04/2016
4Extrapulmonary Tuberculosis
01/2020 - 05/2013
3Disease Progression
01/2023 - 07/2014
3COVID-19 related pediatric multisystem inflammatory disease
01/2023 - 04/2021
3Parasitic Diseases (Parasitic Disease)
01/2017 - 08/2007
2Diabetes Complications
12/2023 - 01/2017
2Hookworm Infections (Hookworm Infection)
12/2023 - 01/2012
2Communicable Diseases (Infectious Diseases)
10/2023 - 01/2022
2Prediabetic State (Prediabetes)
02/2023 - 01/2017
2Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
01/2023 - 01/2023
2Strongyloidiasis
01/2022 - 09/2015
2Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022 - 04/2011
2Obesity
01/2022 - 01/2020
2Filariasis
01/2021 - 04/2006

Drug/Important Bio-Agent (IBA)

93CytokinesIBA
02/2024 - 06/2005
47AntigensIBA
01/2023 - 01/2009
27Biomarkers (Surrogate Marker)IBA
01/2023 - 05/2012
18ChemokinesIBA
02/2024 - 10/2013
14Acute-Phase Proteins (Acute-Phase Protein)IBA
02/2024 - 01/2012
14Interleukin-10 (Interleukin 10)IBA
10/2023 - 01/2012
13Matrix Metalloproteinases (MMPs)IBA
01/2022 - 01/2012
11AnthelminticsIBA
04/2024 - 01/2012
10Interleukin-2 (IL2)IBA
01/2023 - 04/2006
8InterferonsIBA
02/2024 - 07/2009
8C-Reactive ProteinIBA
02/2024 - 01/2013
8AdipokinesIBA
12/2023 - 05/2012
8InterleukinsIBA
10/2023 - 07/2009
8Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2013
8Interleukin-6 (Interleukin 6)IBA
01/2023 - 05/2012
8Interleukin-17 (Interleukin 17)IBA
01/2023 - 01/2009
7Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2024 - 07/2012
7Lipopolysaccharide ReceptorsIBA
11/2021 - 01/2014
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2024 - 01/2009
6Interleukin-12 (IL 12)IBA
02/2024 - 07/2009
6LipopolysaccharidesIBA
07/2021 - 01/2012
5Interleukin-4 (Interleukin 4)IBA
02/2024 - 09/2013
5Immunoglobulin G (IgG)IBA
01/2023 - 05/2017
5Metalloproteases (Metalloproteinases)IBA
01/2022 - 01/2012
5Interleukin-9 (Interleukin 9)IBA
01/2020 - 09/2013
4HaptoglobinsIBA
02/2024 - 01/2012
4IncretinsIBA
12/2023 - 01/2020
4Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
12/2023 - 01/2020
4interleukin-21 (interleukin 21)IBA
01/2022 - 01/2009
4VaccinesIBA
01/2022 - 07/2014
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2021 - 01/2016
3Complement System Proteins (Complement)IBA
04/2024 - 07/2011
3Complement Factor D (Factor D)IBA
04/2024 - 01/2023
3Interleukin-13IBA
02/2024 - 01/2014
3Interleukin-33IBA
02/2024 - 01/2014
3Pancreatic HormonesIBA
12/2023 - 01/2020
3interleukin 20 (IL-20)IBA
10/2023 - 12/2015
3Peptides (Polypeptides)IBA
01/2023 - 01/2017
3Interferon-gamma (Interferon, gamma)IBA
01/2023 - 01/2017
3Heme Oxygenase-1IBA
01/2023 - 01/2013
3Interleukin-15 (Interleukin 15)IBA
01/2022 - 01/2017
3Interleukin-7 (Interleukin 7)IBA
01/2022 - 01/2017
3Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2022 - 04/2012
3LigandsIBA
11/2021 - 04/2006
3lipopolysaccharide-binding proteinIBA
07/2021 - 01/2012
3Toll-Like Receptors (Toll-Like Receptor)IBA
01/2021 - 07/2009
3Glucose (Dextrose)FDA LinkGeneric
12/2020 - 03/2015
3Interleukin-18 (Interleukin 18)IBA
01/2019 - 01/2017
3Messenger RNA (mRNA)IBA
11/2013 - 06/2005
2Complement Factor H (Factor H)IBA
04/2024 - 01/2023
2Complement Factor B (Factor B)IBA
04/2024 - 01/2023
2Amyloid (Amyloid Fibrils)IBA
02/2024 - 07/2021
2Interleukin-5 (Interleukin 5)IBA
02/2024 - 01/2014
2Blood Glucose (Blood Sugar)IBA
12/2023 - 01/2020
2Interleukin-22 (IL-22)IBA
10/2023 - 10/2013
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
10/2023 - 01/2023
2Hemoglobins (Hemoglobin)IBA
02/2023 - 01/2019
2Glucagon (Glukagon)FDA Link
01/2023 - 01/2019
2AdiponectinIBA
01/2023 - 10/2018
2LeptinIBA
01/2023 - 10/2018
2Insulin (Novolin)FDA Link
01/2023 - 01/2019
2Interferon LambdaIBA
10/2022 - 01/2018
2BBV152 COVID-19 vaccineIBA
01/2022 - 01/2021
2MitogensIBA
01/2022 - 01/2017
2IronIBA
01/2022 - 01/2018
2Pregnancy-Associated alpha 2-Macroglobulins (alpha 2 Macroglobulin)IBA
07/2021 - 01/2020
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
04/2021 - 03/2005
2AntibodiesIBA
01/2021 - 01/2021
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2021 - 12/2014

Therapy/Procedure

15Therapeutics
01/2020 - 01/2014
6Drug Therapy (Chemotherapy)
01/2018 - 07/2009
4Immunomodulation
01/2022 - 05/2012
3Glycemic Control
01/2019 - 11/2013